GenrAb
Latest round
- Seed
Last raised
- Apr 2025
Total raised
- $5.6M
Investors
- 4
About GenrAb
GenrAb specializes in creating innovative therapies for neurological care, particularly through monoclonal antibodies. The company is headquartered in Dallas, US, and has completed a total of one deal.6 mn.GenrAb specializes in the development of neuroprotective monoclonal antibodies (mAbs) aimed at addressing the unmet needs in neurological care. Their core product offerings focus on harnessing the power of the human immune system to create therapies that prevent disease progression in various neurological disorders. The flagship candidate, TGM-010, targets a conserved neurodegenerative pathway and has shown promising preclinical results in reducing disability. With the use of their proprietary Antibody Gene Signature (AGS) technology, GenrAb has identified over 400 potentially therapeutic fully-human mAbs that leverage naturally occurring neuroprotective mechanisms.GenrAb's revenue structure is predicated on partnerships and collaborations within the biotechnology and pharmaceutical sectors, focusing on business-to-business transactions. The company engages with research institutions, pharmaceutical companies, and healthcare providers to facilitate the development and eventual commercialization of its neuroprotective therapies. The company is also planning to expand its clinical trials into new markets, specifically targeting regions in North America and Europe by late 2025.
Who invested in GenrAb
4 investors across 1 round
See all investors in GenrAb
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 22, 2025
Amount
$5.6M
Investors
Questions about GenrAb
Who invested in GenrAb?
GenrAb has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GenrAb raised?
GenrAb has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GenrAb last raise money?
GenrAb's most recent round on record is a Seed, in Apr 2025.
What does GenrAb do?
GenrAb specializes in creating innovative therapies for neurological care, particularly through monoclonal antibodies.
Where is GenrAb headquartered?
GenrAb is headquartered in Dallas, US.
Which VCs invest in companies like GenrAb?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at GenrAb's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like GenrAb? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.